Back to search

Article

Prediction of 2-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors Based on a Machine Learning Algorithm

2023-03-28

Abstract excerpt

<h4>Background: </h4> Immune checkpoint inhibitors (ICIs) extend the survival time in patients with advanced non-small-cell lung cancer (NSCLC), but not all patients respond to the treatment. However, current immune-related biomarkers, such as programmed death receptor ligand 1 (PD-L1) and tumor mutation burden(TMB) are limited. We created a machine learning (ML) based clinical decision support algorithm to evalua...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c50de801-62b9-59cd-b9fe-b3835e9d259c
DOI
10.21203/rs.3.rs-2727235/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prediction of 2-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors Based on a Machine Learning AlgorithmDOI 10.21203/rs.3.rs-2727235/v1
Predicting the efficacy of immune checkpoint inhibitors monotherapy in advanced non-small cell lung cancer: a machine learning method based on multidimensional dataSemantic proximity
Characteristics and Hematological Indicators Predictors of Immunotherapy Response in Advanced Non-Small Cell Lung CancerSemantic proximity
Individualized Prognostic Score for Lung Adenocarcinoma Based on Immune StatusSemantic proximity
Efficacy and safety of immune checkpoint inhibitors for EGFR mutated non-small cell lung cancer: a network meta-analysis.Semantic proximity
The Predictive efficacy of tumor mutational burden for immune Checkpoint Inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trialsSemantic proximity
Immune Score Closely Associated With Tumor Microenvironment as A Prognostic Factor in Lung AdenocarcinomaSemantic proximity
A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profilingSemantic proximity
A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.Semantic proximity
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.Semantic proximity
Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer.Semantic proximity
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer.Semantic proximity
Integrating clinico-pathological features and longitudinal liquid biopsy results to predict clinical benefit from immune checkpoint Inhibitors in advanced Non-Small Cell Lung Cancer patientsSemantic proximity
Select a neighboring publication to make it the new centre.